Table 1.

List of webinar and workshop presentations. Presentation slides and webinar recordings can be found online at www.piscltd.org.uk/acute-inhalation-toxicity.

Webinars
Speaker	Affiliation	Title
Ian Indans	Health and Safety Executive, UK	Acute Inhalation Toxicity Testing: The 3Rs, Current Needs and Future Prospects.
Jon Hotchkiss	The Dow Chemical Company	A Primer on Acute Inhalation Toxicity Testing: Where do Alternative Methods Fit?
Marianna Gaca	British American Tobacco	Acute Inhalation Toxicity: In Vitro and Ex Vivo Systems.
Annie Jarabek	U.S. EPA, National Center for Environmental Assessment, ORD	What a Difference the Dose Makes: Dosimetry Approaches to Aid Experimental Design, Evidence Integration, and Inferences for Risk Assessment.
Grace Patlewicz	U.S. EPA, National Center for Computational Toxicology, ORD	State-of-the-Science and Practical Application of In Silico Methods.
Daniel Wilson	The Dow Chemical Company	In Silico Approaches for Acute Inhalation Toxicity.
Marco Corvaro	Dow AgroSciences	GHS Additivity Approach to Classify Mixtures based on Ingredient Toxicity. A Case Example: Agrochemical Formulations.
Mathieu Vinken	Free University of Brussels	Adverse Outcome Pathways as Tools to Assess Chemical-Induced Toxicity.
Barbara Buckley	U.S. EPA, National Center for Environmental Assessment, ORD	A Conceptual Model for Assessing Criteria Air Pollutants in a Multipollutant Context: A Modified Adverse Outcome Pathway Approach.
Kelly BéruBé	School of Biosciences, Cardiff University	The NHBE and Metabo-Lung™ Models: Normal and Metabolizing In Vitro Alternatives for Lung Research.
Dongeun Huh	University of Pennsylvania	Microengineered Physiological Bio-mimicry: Human Organs-on-Chips.
Workshop presentations
Jon Hotchkiss	The Dow Chemical Company	The Case for an Integrated Approach to Acute Inhalation Toxicity Testing and Assessment
Dan Wilson	The Dow Chemical Company	An Alternative Framework for Acute toxicity using Mechanistic In Silico and In Vitro Approaches
Paul Hinderliter	Syngenta	An Alternative Approach for Evaluating the Human Health Risk from Exposure to an Irritant Aerosol
Michael Bartels	ToxMetrics.com, LLC	Toxicokinetics in Risk Assessment: Evaluation of In Silico Approaches
Miyoung Yoon	ScitoVation, LLC	Assessing Bioavailability and Systemic Delivery of Inhaled Compounds: Current Status and Future Directions
Anna Lowit	U.S. EPA Office of Pesticide Programs	U.S. EPA OPP Regulatory Perspective on Acute Inhalation Toxicity Testing
Iris Camacho	U.S. EPA Office of Pollution Prevention and Toxics	U.S. EPA OPPT Regulatory Perspective on Acute Inhalation Toxicity Testing
Grace Patlewicz	U.S. EPA, National Center for Computational Toxicology, ORD	ICCVAM’s Vision and Strategy for Acute Toxicity Testing